GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FVCB · Sep 30, 2024

FVCBankcorp, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001675644-24-000192Bank
Sequential deposit growth30thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-0.41% · CORE · VALID

Net-income growth50thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

15.60% · CORE · VALID

Interest-income growth55thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

6.58% · CORE · VALID

Cash and equivalents25thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$10.1M · CORE · VALID

Sequential loan growth25thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

-0.63% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History32 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
6.00%
Current
-0.41%
Delta
-6.41%
Earnings Growth Increased
Previous
-1.84%
Current
15.60%
Delta
17.44%
Interest Income Growth Increased
Previous
2.83%
Current
6.58%
Delta
3.76%
Liquidity Decreased
Previous
$10.2M
Current
$10.1M
Delta
-$137,000
Loan Growth Decreased
Previous
1.85%
Current
-0.63%
Delta
-2.48%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.